Genopathy
Gene-Disorder Association · Article
Gene
BRCA1
BRCA1 DNA Repair Associated
Manually curatedApproved treatment annotated
Association Review

In brief

The association between BRCA1 (BRCA1 DNA Repair Associated) and Ovarian Cancer is well established and manually curated, with its 3 contributing sources — 2 of them expert-curated — recording pathogenic variants and causative variation.

Sources 3
Clinical variants 6,645
Symptoms 8
Compounds 9
Trials 847of 10,744 via BRCA1 compounds
Publications 817
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

3 sources

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
BRCA1

The gene

2 source summaries

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Ovarian Cancer

The disorder

19 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Phenotype

Clinical features

3 clinical features

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Request access
06
ClinVar and variant evidence

Genetic basis

6,645 clinical variants

ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.

Request access
07
Mechanism overlap

Shared mechanisms

Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.

Request access
08
Interventions

Therapeutics

9 compounds & drugs

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
09
Human studies

Clinical trials

10,744 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
10
Literature

Reading

817 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
11
Provenance

References & sources

18 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access